Skip to main content

Find Clinical Trials

Home
Conditions
Neuroendocrine Tumors

Clinical trial condition

Neuroendocrine Tumors

Explore clinical trials studying Neuroendocrine Tumors. Study availability and eligibility vary by location and protocol.

2,768 public trials 494 recruiting studies

Refine in advanced search Browse all conditions

Neuroendocrine Tumors trial results

Not Yet Recruiting

Clinical and Ultrasound Incidence of Rheumatologic Immune Related Adverse Events in Stage IIB-IV Melanoma Patients

NCT06780397

Conditions: Melanoma, Melanoma Stage III, Melanoma Stage IV, +12 more
Locations: Fondazione Policlinico Universitario A. Gemelli IRCCS, UOC Dermatologia Rome, Lazio, Italy

View Trial Details

Not Yet Recruiting

Power of Liquid Biopsy Tracking in Immunotherapy Treated Stage IV Melanoma

NCT06710093

Conditions: Melanoma, Metastatic Melanoma, Neoplasms, +10 more
Locations: The Royal Marsden Chelsea, London, United Kingdom

View Trial Details

Not Yet Recruiting

Phase I/IIa Dose Finding Study of Triplet Regimen of Relatlimab Ipilimumab and NIvolumab in First Line Therapy of Metastatic Melanoma (TRINITY)

NCT06683755

Conditions: Melanoma, Neoplasms, Neoplasms by Histologic Type, +9 more
Locations: The University of Texas M. D. Anderson Cancer Center Houston, Texas, United States

View Trial Details

Not Yet Recruiting

Clinical Observation on the Safety and Efficacy of Cardonilmab in the Treatment of Second-line and Above Advanced Melanoma and Advanced Renal Cancer

NCT06670300

Conditions: Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Kidney Diseases, +19 more
Locations: the Affiliated Cancer Hospital of Zhengzhou University & Henan Cancer Hospital Zhengzhou, China

View Trial Details

Not Yet Recruiting

An Observational Study Using The LumAssure Device In Participants Undergoing Assessment Of Skin Conditions.

NCT06661577

Conditions: Acral Melanoma, Benign Skin Nevus, Benign Skin Tumor, +21 more
Locations: Manukau Super clinic Auckland, New Zealand

Sir Willliam Manchester Plastic surgery suite, Middlemore Hosptial Auckland, New Zealand

View Trial Details

Not Yet Recruiting

Gene Expression Profiles and ctDNA for Risk Stratification in Patients With Melanoma

NCT06566404

Conditions: Melanoma, Neoplasms, Neoplasms by Histologic Type, +9 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

A Single-arm, Multicenter Clinical Study of Fruquintinib Combined With Cadonilimab Injection and Temozolomide in Second-line and Subsequent Treatment of Advanced Melanoma

NCT06553781

Conditions: Malignant Melanoma, Melanoma, Neoplasms, +10 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

TQB2916 Injection Combined With Chemotherapy or Penpulimab Injection in the Treatment of Solid Tumors

NCT06500091

Conditions: Melanoma, Neoplasms, Neoplasms by Histologic Type, +12 more
Locations: Cancer Hospital Chinese Academy of Medical Science Beijing, Beijing Municipality, China

Beijing Cancer Hospital Beijing, Beijing Municipality, China

Henan Cancer Hospital Affiliated Cancer Hospital of Zhengzhou University Zhengzhou, Henan, China

Hunan Cancer Hospital Changsha, Hunan, China

View Trial Details

Not Yet Recruiting

Circulating Tumour DNA Guided Adaptive BRAF and MEK Inhibitor Therapy

NCT06470880

Conditions: Melanoma, Neoplasms, Neoplasms by Histologic Type, +9 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

Identification and Characterization of Circulating Tumor Cells Before and After Treatment (Surgery and Radiotherapy) in a Cohort of Patients Treated for Resectable Stage I-III Merkel Cell Carcinoma

NCT06448611

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Merkel Cell, +19 more
Locations: Not specified

View Trial Details